Radiation-induced neoantigens broaden the immunotherapeutic window of cancers with low mutational loads
<jats:p>Immunotherapies are a promising advance in cancer treatment. However, because only a subset of cancer patients benefits from these treatments it is important to find mechanisms that will broaden the responding patient population. Generally, tumors with high mutational burdens have the...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Proceedings of the National Academy of Sciences
2021
|
Online Access: | https://hdl.handle.net/1721.1/135643 |